Miguel-Angel Perales focuses on Immunology, Transplantation, Internal medicine, Hematopoietic stem cell transplantation and Surgery. His work in Immunology tackles topics such as Stem cell which are related to areas like Viral replication and Virology. The concepts of his Transplantation study are interwoven with issues in Human leukocyte antigen, Chemotherapy, Retrospective cohort study and Hazard ratio.
His research in Internal medicine intersects with topics in Gastroenterology, Transplantation Conditioning and Oncology. His Hematopoietic stem cell transplantation research incorporates themes from Survival rate, Haematopoiesis and Bacteremia, Antibiotics. His biological study spans a wide range of topics, including Refractory Hodgkin Lymphoma, Adverse effect and Lymphoma.
Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Oncology are his primary areas of study. His work deals with themes such as Gastroenterology, CD34 and Surgery, which intersect with Internal medicine. In his study, Intensive care medicine is strongly linked to Hematopoietic cell, which falls under the umbrella field of Transplantation.
Miguel-Angel Perales has researched Hematopoietic stem cell transplantation in several fields, including Cancer, Transplantation Conditioning, Leukemia and Retrospective cohort study. Miguel-Angel Perales works mostly in the field of Oncology, limiting it down to topics relating to Chimeric antigen receptor and, in certain cases, Diffuse large B-cell lymphoma, as a part of the same area of interest. His Graft-versus-host disease study combines topics from a wide range of disciplines, such as Cyclophosphamide and Calcineurin.
His primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic cell and Hematopoietic stem cell transplantation. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Cell therapy. His Transplantation research incorporates elements of Immune system, Immunology and Incidence, Cumulative incidence.
His Immunology research includes themes of Microbiome and Myeloablative conditioning. As a part of the same scientific study, Miguel-Angel Perales usually deals with the Oncology, concentrating on Stem cell and frequently concerns with Proteasome inhibitor and Myeloid leukemia. Within one scientific family, Miguel-Angel Perales focuses on topics pertaining to Cohort study under Hematopoietic stem cell transplantation, and may sometimes address concerns connected to Survival rate and Proportional hazards model.
His main research concerns Internal medicine, Transplantation, Chimeric antigen receptor, Hematopoietic stem cell transplantation and Gastroenterology. His Internal medicine study often links to related topics such as Oncology. His Transplantation research integrates issues from Hematopoietic cell, MEDLINE, Neutropenia, Clinical endpoint and Hazard ratio.
His Hematopoietic stem cell transplantation study incorporates themes from Hematology, Immunosuppression and Cohort study. The various areas that Miguel-Angel Perales examines in his Gastroenterology study include Adverse effect and Anemia. In his work, Immune system is strongly intertwined with Mycophenolate, which is a subfield of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Ying Taur;Joao B. Xavier;Lauren Lipuma;Carles Ubeda.
Clinical Infectious Diseases (2012)
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
Ying Taur;Ying Taur;Robert R Jenq;Robert R Jenq;Miguel Angel Perales;Miguel Angel Perales;Eric R. Littmann.
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey.
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R. Jenq;Robert R. Jenq;Ying Taur;Ying Taur;Sean M. Devlin;Doris M. Ponce;Doris M. Ponce.
Biology of Blood and Marrow Transplantation (2015)
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
P.J. Bergman;M.A. Camps-Palau;J.A. McKnight;N.F. Leibman.
Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease
Onder Alpdogan;Cornelius Schmaltz;Stephanie J. Muriglan;Barry J. Kappel.
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.
Adam D. Cohen;Adi Diab;Miguel Angel Perales;Miguel Angel Perales;Jedd D. Wolchok;Jedd D. Wolchok.
Cancer Research (2006)
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
Craig H. Moskowitz;Matt J. Matasar;Andrew D. Zelenetz;Stephen D. Nimer.
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey;Mei Jie Zhang;Shannon R. McCurdy;Andrew St Martin.
Journal of Clinical Oncology (2017)
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.
Abraham S. Kanate;Alberto Mussetti;Mohamed A. Kharfan-Dabaja;Kwang W. Ahn;Kwang W. Ahn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: